Key Points
Thevaccinecontains a weakened form of liveinfluenzavirus strains and is sprayed in the nose, and a prescription is still required to receive FluMist...
The development comes even as Indias nasalfluvaccineNasovac S4developed by Pune based Serum Institute of India (SII) and marketed and distributed by diagnostic company Mylablaunched last year is yet to find a foothold in the country...
According to the Indian Academy of Pediatrics (IAP)the largest network of paediatricians in the countryfluvaccinesshould be taken annually by kids aged between six months and 5 years and those with high-risk conditions...
Launched in India in November last year, Nasovac S4 is a live quadrivalentinfluenzavaccinecontaining fourinfluenzavaccinevirus strains, aligning with WHO recommendations, but a dose of 0.5 ml is administeredvia a syringe and a spray device supplied with thevaccine...
We can say that the acceptability of the nasalvaccineis not high at present, but with more data emerging in the future, as well as the convenience of its use, it is likely that more people will accept it in due course, he said.. Dr Vikas Mittal, pulmonologist with CK Birla Hospital in Delhi, too, underlined that nasalinfluenzavaccineis a recent launch and is yet to become widely available in pharmacies or introduced to doctors...
You might be interested in
‘Ease of administration, reduced hesitancy’ — India’s 1st nasal flu vaccine raises hope of acceptance
01, Nov, 23Mylab & Serum Institute of India launched Nasovac S4 last week. It's being seen as major step towards increasing acceptance of flu vaccines in India, where uptake has been low.
India logs third highest number of children not vaccinated against measles after Nigeria and Congo
18, Jul, 24India is among 10 countries that account for 55 percent of children without measles vaccination globally, show WHO-UNICEF estimates of national immunisation coverage.
You may not need a fourth Covid vaccine now but a flu shot
26, Jul, 23Public health experts suggest that a fourth dose of the Covid vaccine is unnecessary for now. With only 220 million people taking the third dose, a fourth dose may help build resistance, but health experts don't see the need for it as Covid cases in India have drastically decreased. Instead, considering the high number of flu cases in India's cities, vaccinating against flu may be a better idea.